1-4 of 4
Loic Bergougnoux
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Once Weekly Epoetin Beta 30 000 IU in 691 Patients with Solid or Lymphoid Malignancies Receiving Chemotherapy: Results from the NAUTICA Study.

Dominique Spaeth, Gilles Salles, Thierry Facon, Reda Garidi, Francois Pichon, Ghandi Damaj, Loic Bergougnoux
Journal: Blood
Blood (2006) 108 (11): 3758.
https://doi.org/10.1182/blood.V108.11.3758.3758
Published: 2006
Journal Articles

Single Treatment with Rituximab Monotherapy for Low-Tumor Burden Follicular Lymphoma (FL): Survival Analyses with Extended Follow-Up (F/Up) of 7 Years.

Philippe Colombat, Nicole Brousse, Franck Morschhauser, Patricia Franchi-Rezgui, Pierre Soubeyran, Vincent Delwail, Eric Deconinck, Corinne Haioun, Charles Foussard, Catherine Sebban, Herve Tilly, Noel-Jean Milpied, Francois Boue, Jean-Michel Karsenti, Pierre Lederlin, Albert Najman, Catherine Thieblemont, Delphine Moreau, Loic Bergougnoux, Gilles Andre Salles, Philippe Solal-Celigny
Journal: Blood
Blood (2006) 108 (11): 486.
https://doi.org/10.1182/blood.V108.11.486.486
Published: 2006
Journal Articles

Single 4-Dose Rituximab Treatment for Low-Tumor Burden Follicular Lymphoma (FL): Survival Analyses with a Follow-Up (F/Up) of at Least 5 Years.

Philippe Solal-Celigny, MD, PhD, Gilles Andre Salles, MD, PhD, Nicole Brousse, MD, Patricia Franchi-Rezgui, MD, Pierre Soubeyran, MD, PhD, Vincent Delwail, MD, Eric Deconinck, MD, Corinne Haioun, MD, PhD, Charles Foussard, MD, Catherine Sebban, MD, Herve Tilly, MD, PhD, Noel-Jean Milpied, MD, PhD, Francois Boue, MD, Jean-Michel Karsenti, MD, Pierre Lederlin, MD, PhD, Albert Najman, MD, Catherine Thieblemont, MD, PhD, Franck Morschhauser, MD, Nathalie Berriot-Varoqueaux, MD, PhD, Loic Bergougnoux, Philippe Colombat, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 585.
https://doi.org/10.1182/blood.V104.11.585.585
Published: 2004
Journal Articles

Rituximab Given after High Dose Therapy and Autologous Stem Cell Transplantation Induces Durable Clearance of Minimal Residual Disease in about Half of the Patients with Follicular Non Hodgkin’s Lymphoma : 36 Months Results of a Multicenter Open Label Phase II Trial (M39012 Trial).

Franck Morschhauser, Christian Recher, Noel Milpied, Remi Gressin, Gilles Salles, Pauline Brice, Norbert Vey, Corinne Haioun, Philippe Colombat, Jean-Henri Bourhis, Jean-Francois Rossi, Nathalie Berriot-Varoqueaux, Loic Bergougnoux, Andre Bosly, Georges Delsol, Michel Attal
Journal: Blood
Blood (2004) 104 (11): 747.
https://doi.org/10.1182/blood.V104.11.747.747
Published: 2004